Larimar Therapeutics, Inc. · NASDAQ:LRMR

Celano Michael bought 18,460 Larimar Therapeutics, Inc. shares (Form 4)

Traded Nov 11, 2026 · Filed Nov 12, 2026

On Nov 11, 2026, Celano Michael (Chief Financial Officer) bought 18,460 Larimar Therapeutics, Inc. shares at US$2.71 for US$49,992, leaving 234,245 shares. Filed Nov 12, 2026 (Form 4).

Bought
18,460 shares
Price
US$2.71
Value
US$49,992
Holding after
234,245 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 11, 2026Common StockBuy18,460US$2.71234,245Direct

Source

Download original · View original at SEC

Related